Bill · H.R. 7871· House(119-HR-7871)

MVP Act

Age: 62 years

Kentucky

Introduced: 3/9/2026
Last activity: 3/9/2026 — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sponsored by: Brett Guthrie
Cosponsors: - 11 - 6

Health

Introduced
In Committee

What this bill would do

The Medicaid VBPs for Patients Act aims to amend the Social Security Act to codify value-based purchasing arrangements within the Medicaid program. It allows manufacturers to offer multiple best price points for a single drug if the arrangement is offered to all States. The bill also updates how the average manufacturer price is defined, specifically regarding payments triggered by patient outcomes. Additionally, it directs the Secretary of Health and Human Services to provide guidance on inpatient drug arrangements. Finally, the Act includes an exception under the Anti-Kickback Statute and mandates a GAO study to evaluate the impact of these arrangements.

Yes· 3 of 7

Does this make health care easier to get in general?+4
The bill provides mechanisms to facilitate patient access to transformative therapies and mitigate socioeconomic disparities in drug access.
Does this reduce what the federal government spends?+3
The bill aims to lower overall health system costs and Medicaid expenditures through value-based purchasing arrangements.
Does this put more money into Medicaid, the health coverage for people on low incomes?+2
By allowing multiple best price points and value-based arrangements, the bill seeks to optimize drug costs within the Medicaid program.